marijuana stocks

Cara reports 4Q loss

Cara Therapeutics posts loss of $4.2 million in 4th quarter

SHELTON, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a fourth-quarter loss of $4.2 million, after reporting a profit in the same period a year earlier.

The Shelton, Connecticut-based company said it had a loss of 18 cents per share.

The biotechnology company posted revenue of $914,000 in the period.

For the year, the company reported that its loss widened to $17.7 million, or 85 cents per share. Revenue was reported as $3.2 million.

Cara shares have fallen nearly 7 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.30, a drop of 45 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

_____

Keywords: Cara Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

22nd Century Group, Inc. (XXII) Files 2019 Annual Report

22nd Century Group, Inc. Files 2019 Annual Report 22nd Century Group, Inc. (NYSE…

The Alkaline Water Company Inc. (WTER) Launches A88CBD™ Ingestibles Product Line

The Alkaline Water Company Launches A88CBD™ Ingestibles Product Line   The Alkaline…

$NVLX “It’s My Cell-in-a-Box”

Nuvilex Applies to FDA for Orphan Drug Designation for Its Cell-in-a-Box(R) Treatment…

Verano Holdings Corp. (VRNOF) Announces the Opening of MÜV Winter Springs,

Verano Announces the Opening of MÜV Winter Springs, the Company’s 66th Florida…